Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy-Reference-Cited by-同舟云学术

Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy

Published:2015-11-26 Issue:6 Volume:17 Page:471-478
ISSN:1464-2662
Container-title:HIV Medicine
language:en
Short-container-title:HIV Med

Author:

Winston A¹,Stöhr W²,Antinori A³,Arenas-Pinto A²,Llibre JM⁴⁵,Amieva H⁶,Cabié A⁷,Williams I⁸,Di Perri G⁹¹⁰,Tellez MJ¹¹,Rockstroh J¹²,Babiker A²,Pozniak A¹³,Raffi F¹⁴,Richert L⁶¹⁵,

Affiliation:

1. Department of Medicine; Imperial College London; London UK

2. MRC Clinical Trials Unit at University College London; London UK

3. Clinical Department; National Institute for Infectious Diseases Lazzaro Spallanzani IRCCS; Rome Italy

4. HIV Unit and Lluita contra la SIDA Foundation; University Hospital Germans Trias i Pujol; Badalona Spain

5. Universitat Autonoma de Barcelona; Barcelona Spain

6. Centre Inserm U897-Epidemiologie-Biostatistique; University of Bordeaux, ISPED; Bordeaux France

7. Department of Infectious and Tropical Diseases and INSERM CIE802; University Hospital of Fort-de-France; Fort-de-France Martinique France

8. Centre for Sexual Health and HIV Research; Mortimer Market Centre; University College London; London UK

9. Laboratory of Clinical Pharmacology and Pharmacogenetics (2); Unit of Infectious Diseases; University of Turin; Turin Italy

10. Department of Medical Sciences; Amedeo di Savoia Hospital; Turin Italy

11. Infectious Diseases Unit; Internal Medicine; Hospital Clinico Universitario; Madrid Spain

12. Department of General Internal Medicine I; University Hospital of Bonn; Bonn Germany

13. Chelsea and Westminster NHS Foundation Trust; London UK

14. CMIT; Paris France

15. CHU de Bordeaux, Pole de sante publique, and CIC1401-EC (Clinical Epidemiology); Bordeaux France

Funder

Sixth Framework Programme

Gilead Sciences

Janssen Pharmaceuticals

Merck Laboratories

French National Institute for Health and Medical Research-France Recherche

Nord&Sud Sida-HIV Hepatites (Inserm-ANRS)

Publisher

Wiley

Subject

Pharmacology (medical),Infectious Diseases,Health Policy

Reference17 articles.

1. Changes to AIDS dementia complex in the era of highly active antiretroviral therapy;Dore;AIDS,1999

2. HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: differences in rates, nature, and predictors;Heaton;J Neurovirol,2011

3. Cognitive dysfunction in HIV patients despite long-standing suppression of viremia;Simioni;AIDS,2010

4. Low prevalence of neurocognitive impairment in early diagnosed and managed HIV-infected persons;Crum-Cianflone;Neurology,2013

5. CD4 nadir is a predictor of HIV neurocognitive impairment in the era of combination antiretroviral therapy;Ellis;AIDS,2011

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pidotimod and Immunological Activation in Individuals Infected with HIV;Current HIV Research;2021-05-06

2. A cohort study: The Association Between Autoimmune Disorders and Leptospirosis;Scientific Reports;2020-02-24

3. Neuropsychological and Syntactic Deficits in HIV Seropositive Males;The Open Neurology Journal;2019-09-30

4. EcoHIV infection of mice establishes latent viral reservoirs in T cells and active viral reservoirs in macrophages that are sufficient for induction of neurocognitive impairment;PLOS Pathogens;2018-06-07

5. Changes in Cognitive Function Over 96 Weeks in Naive Patients Randomized to Darunavir–Ritonavir Plus Either Raltegravir or Tenofovir–Emtricitabine;JAIDS Journal of Acquired Immune Deficiency Syndromes;2017-02